In this respect, TDM can be used, along with clinical monitoring of patients, and together with an awareness of the pharmacokinetic profiles of specific agents, to optimise treatment outcomes.
The new benchtop CellScape system builds on the existing core strengths of the original ChipCytometry instrument, the ZellScannerONEâ„¢, which has enabled spatial biology research with sub-cellular ...